Sources | Names Used |
---|---|
CTRPv2 | selumetinib:BRD-A02303741 (4:1 mol/mol) |
PharmacoGx | selumetinib:BRD-A02303741 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ATXN2L | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-05 |
mRNA | ATXN7L1 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | TMEM8B | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
mRNA | SUCLG2 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | TOPBP1 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
mRNA | FCGR2A | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | PRAF2 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-05 |
mRNA | MIS18A | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
mRNA | GNAZ | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
mRNA | NCAPD3 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |